The following table is for layout only
Goto Main Navigation
|
Goto Main Content
|
Goto Banner
|
Goto Logon Box
|
Goto Menu Bar
|
Goto Search Box
|
Goto Footer
Register
|
Log in
Home
|
About us
|
Contact us
Return to Listing
Data
Analytical tools
National lead areas
International work
Health topics
Publications
Events & Training
Return to Listing
Commissioning - PCT Clinical Exceptions - Reviews
Home Location
LHO
National or Regional
Regional
start of decorative frame for
Relationships
start of content for
Is part of
Dual channel function electrical stimulation for the treatment of multiple sclerosis (MS)
Has part
8-weekly (scheduled) Infliximab treatment of a patient with non-fistulating Crohn’s disease
Adalimumab therapy for severe Crohn’s disease
Adalimumab to treat ankylosing spondylitis (AS)
Adalimumab treatment for rheumatoid arthritis (RA)
Bilateral cochlear implant for a patient with bilateral sensorineural hearing loss
Dasatinib for chronic-phase chronic myeloid leukaemia (CP-CML) refractory to imatinib.
Dual channel function electrical stimulation for the treatment of multiple sclerosis (MS)
Evidence of the effectiveness of magneto-encephalography as a diagnostic tool for a child who has Landau-Kleffner syndrome, or acquired epileptic aphasia
Infliximab infusions to treat ocular sarcoidosis
Intravenous immunoglobulin (IVIG) for multiple sclerosis (MS)
Intravenous immunoiglobulin (IVIG) for treatment of multifocal motor neuropathy (MMN)
Macugen therapy for a patient with exudative (wet) age related macular degeneration (ARMD)
Nilotinib for chronic-phase chronic myeloid leukaemia refractory to Imatinib.
Octreotide for the treatment of a child with congenital hyperinsulinaemic hypoglycaemia
Pegylated-liposomal doxorubicin (Caelyx) for treatment of recurrent angiosarcoma of the scalp
Photodynamic therapy (PDT) for punctate inner choroidopathy (PIC) with choroidal neovascularisation (CNV)
Rituximab for severe chronic immune thrombocytopenic purpura refractory to steroids, immunoglobulin and anti-D therapy, with a concurrent history of primary biliary cirrhosis.
Sorafenib for metastatic hepatocellular carcinoma
Sorafenib for metastatic renal cell cancer
The effectiveness of bone anchored hearing aids (BAHAs) for a patient who has profound mixed bilateral hearing loss
Voriconazole for the treatment of severe allergic bronchopulmonary aspergillosis leading to chronic cavitary bronchopulmonary aspergillosis
Wireless capsule endoscopy (WCE) for obscure gastrointestinal (GI) bleeding
Wireless capsule endoscopy (WCE) for small bowel Crohn’s disease
8-weekly (scheduled) treatment of complex Crohn’s disease patient with Infliximab
Evidence for the use of infliximab in the treatment of Behcet’s disease
Fitting and maintenance of a prosthetic C-leg for a left femoral amputee (non standard prosthesis)
Paclitaxel as adjuvant chemotherapy for early breast cancer
Pemetrexed for malignant pleural mesothelioma
Sodium oxybate for treatment of cataplexy
Adalimumab treatment for a patient with severe fistulating Crohn’s disease
Continuous positive air pressure (CPAP) for sleep-disordered breathing
Endovascular repair of abdominal aortic aneurysm (AAA) with aortic stent
Hyperbaric oxygen (HBO) therapy for a patient with non-healed diabetic wound
Magnetic resonance-guided focused ultrasound (MRgFUS) for uterine fibroid
Sildenafil (in combination with sitaxentan sodium) for treatment of pulmonary arterial hypertension (PAH)
Trabectedin for myxoid liposarcoma
Pemetrexed and cisplatin for the treatment of metastatic malignant mesothelioma
Infliximab for the treatment of uveitis in a 10 year-old child
Use of infliximab in a 12 year old child with Crohn’s disease
Percutaneous aortic valve replacement in a patient with severe aortic stenosis
end of content for
end of decorative frame for
start of decorative frame for
You might also be interested in...
start of content for
Commissioning - PCT Clinical Exceptions - Oncology
Commissioning - PCT Clinical Exceptions - Gastrointestinal Diseases
Commissioning - PCT Clinical Exceptions - Neurology
Commissioning - PCT Clinical Exceptions - Ophthalmology
Commissioning - PCT Clinical Exceptions - Prostheses & implants
More...
end of content for
end of decorative frame for
start of decorative frame for
Type and Language
Type and Language
start of content for
Type and Language
Resource Type
collection
end of content for Type and Language
end of decorative frame for Type and Language
Stay in touch
Corporate
Site help
Return to listing
© Public Health England, London Knowledge and Intelligence Team, Wellington House, 133-155 Waterloo Road, London SE1 8UG, Tel: 020 7654 8307